---
figid: PMC8615865__biomolecules-11-01697-g003
figtitle: Nanoscale Sub-Compartmentalization of the Dendritic Spine Compartment
organisms:
- NA
pmcid: PMC8615865
filename: biomolecules-11-01697-g003.jpg
figlink: /pmc/articles/PMC8615865/figure/biomolecules-11-01697-f003/
number: F3
caption: 'Schematic diagram of a vomposite synapse summarizing the pre- and postsynaptic
  components participating in synaptic signaling dissected in this review. Glutamatergic
  (Glu) and cholinergic (α7 nAChR) activation promotes Ca2+ entry into the dendritic
  spine, inducing endocannabinoid (eCB) synthesis through hydrolysis of lipid precursors
  from the cell membrane. Cannabinoid receptor (CBR) activation in dendritic spines
  inhibits Rac1/WAVE/Arp 2/3 and limits the conversion of G actin to F-actin, whereas
  α7 nAChR promotes formation and maturation of dendritic spines through F-actin stability
  by activating the Rac1/WAVE/Arp2/3 signaling pathway. Phospholipase C (PLC) converts
  PIP2 into diacylglycerol (DAG) and in turn DAG lipase (DAGL) generates the eCB 2-AG.
  In parallel, phospholipase D (PLD) converts N-arachidonoyl phosphatidylethanolamine
  into the eCB AN. 2-AG and AN are liberated into the synaptic cleft and activate
  CBRs in the presynaptic compartment. Upon activation, CBRs stimulate Gi-protein
  and inhibit AC activity, membrane hyperpolarization ensues after the modulation
  of K+ and Ca2+ channels that inhibit neurotransmitter release from the presynaptic
  compartment. Finally, the mitogen-activated protein kinase (MAPK) pathway is stimulated.
  AC: adenyl cyclase; cAMP: cyclic AMP; ACh; acetylcholine; 2-AG, 2-arachidonyl glycerol.'
papertitle: Nanoscale Sub-Compartmentalization of the Dendritic Spine Compartment.
reftext: Ana Sofía Vallés, et al. Biomolecules. 2021 Nov;11(11):1697.
year: '2021'
doi: 10.3390/biom11111697
journal_title: Biomolecules
journal_nlm_ta: Biomolecules
publisher_name: MDPI
keywords: dendritic spine | plasma membrane | membrane domains | nanodomains | neurotransmitter
  receptors | cannabinoids | acetylcholine receptor | glutamatergic receptor | NMDAR
  | AMPAR | cannabinoid receptor | GPCR
automl_pathway: 0.9708492
figid_alias: PMC8615865__F3
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC8615865__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8615865__biomolecules-11-01697-g003.html
  '@type': Dataset
  description: 'Schematic diagram of a vomposite synapse summarizing the pre- and
    postsynaptic components participating in synaptic signaling dissected in this
    review. Glutamatergic (Glu) and cholinergic (α7 nAChR) activation promotes Ca2+
    entry into the dendritic spine, inducing endocannabinoid (eCB) synthesis through
    hydrolysis of lipid precursors from the cell membrane. Cannabinoid receptor (CBR)
    activation in dendritic spines inhibits Rac1/WAVE/Arp 2/3 and limits the conversion
    of G actin to F-actin, whereas α7 nAChR promotes formation and maturation of dendritic
    spines through F-actin stability by activating the Rac1/WAVE/Arp2/3 signaling
    pathway. Phospholipase C (PLC) converts PIP2 into diacylglycerol (DAG) and in
    turn DAG lipase (DAGL) generates the eCB 2-AG. In parallel, phospholipase D (PLD)
    converts N-arachidonoyl phosphatidylethanolamine into the eCB AN. 2-AG and AN
    are liberated into the synaptic cleft and activate CBRs in the presynaptic compartment.
    Upon activation, CBRs stimulate Gi-protein and inhibit AC activity, membrane hyperpolarization
    ensues after the modulation of K+ and Ca2+ channels that inhibit neurotransmitter
    release from the presynaptic compartment. Finally, the mitogen-activated protein
    kinase (MAPK) pathway is stimulated. AC: adenyl cyclase; cAMP: cyclic AMP; ACh;
    acetylcholine; 2-AG, 2-arachidonyl glycerol.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pld
  - inaE
  - an
  - MKP-4
  - p38b
  - rl
  - norpA
  - sl
  - Plc21C
  - ac
  - GluRIIC
  - GluRIIA
  - mGluR
  - Cat
  - Ca-alpha1T
  - ChAT
  - sv
  - SCAR
  - Arp2
  - Arp3
  - Arfrp1
  - Arp6
  - Su(z)2
  - Arp1
  - nAChRalpha3
  - nAChRalpha7
  - nAChRbeta3
  - nAChRalpha6
  - nAChRalpha5
  - nAChRbeta1
  - nAChRalpha4
  - nAChRalpha1
  - nAChRalpha2
  - nAChRbeta2
  - Rac1
  - Rac2
  - achi
  - emc
  - Act5C
  - ca
  - GPLD1
  - PLD1
  - PLD2
  - PLD3
  - PLD4
  - PLD5
  - PLD6
  - AN
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - CAT
  - CRAT
  - GLYAT
  - WASF1
  - CBR1
  - CNR1
  - ACTR2
  - ANGPTL2
  - AICDA
  - ACTR3
  - APOBEC3A
  - CRISP1
  - RERE
  - MANF
  - ARFRP1
  - CHRNA4
  - RAC1
  - RNASE1
  - FGFR3
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
---
